newsfilter
← Latest News
GlobeNewswire·

SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit

SKIN
  • SkinHealth Systems (NASDAQ: SKIN) announced two new clinical studies on HydraScalp with Keravive and Hydrafacial treatments will be presented at the Science of Skin Summit in Austin, Texas, from September 17-20, 2026.
  • A randomized, evaluator-blinded study found a single HydraScalp treatment significantly improved scalp hydration, reduced dryness and dandruff, enhanced smoothness, maintained epidermal barrier integrity, and optimized the scalp microenvironment.
  • A Phase IV open-label study evaluated monthly Deluxe Hydrafacial treatments with the ReGen GF Booster across Fitzpatrick skin types I-VI, showing 100% of subjects achieved Global Aesthetic Improvement.
  • The Hydrafacial study reported statistically significant improvements in skin hydration, roughness, wrinkle appearance, elasticity, and pore size, with benefits observed across all skin types.
  • Both studies reinforce the efficacy of these treatments for a broad range of skin and scalp concerns, supporting their integration into provider practices.
  • Digital e-posters containing the study findings will be displayed on touchscreen monitors and accessible via the Science of Skin Summit mobile app.